Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ganoderic acid D is a bioactive triterpene compound derived from Ganoderma lucidum (reishi mushrooms) that modulates immune function and liver health. This compound works by inhibiting inflammatory cytokines and enhancing hepatocyte protection through antioxidant pathways.
Reported Benefits (Provisional)
Origin & History
Ganoderic Acid D is a bioactive compound found in Ganoderma lucidum, commonly known as reishi or lingzhi mushrooms. This compound is extracted through advanced processing techniques to harness its potential health benefits.
Research Narrative (Provisional)
Ganoderic Acid D has been studied for its potential anti-inflammatory and immunomodulatory effects. Some research includes animal studies and preliminary human trials, but more research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Ganoderic Acid D is a lanostane-type triterpenoid isolated primarily from Ganoderma lucidum (Reishi mushroom) fruiting bodies and spores. It is not a macronutrient source but rather a bioactive secondary metabolite. Typical concentration in dried Reishi fruiting bodies ranges from approximately 0.01–0.15% w/w, though this varies significantly by strain, cultivation substrate, and extraction method. Key characteristics: Chemical class: Lanostane triterpenoid (C30H44O7, MW ~520.66 g/mol). Bioactive compounds co-occurring in source material: Other ganoderic acids (A, B, C, F, G, H, etc.), lucidenic acids, ganodermanontriol, beta-glucans (polysaccharides, ~25–45% of dry weight in whole fruiting body), ergosterol (provitamin D2, ~0.3–0.6% dry weight), and trace minerals including selenium (~0.5–2.0 µg/g), germanium (~0.01–0.05% in some strains), zinc (~5–10 mg/100g), and potassium (~200–400 mg/100g). Protein content of whole Reishi is approximately 7–13% dry weight; fiber (including chitin and beta-glucans) approximately 25–55% dry weight; fat approximately 2–5% dry weight, largely comprising fatty acids and triterpenes. Vitamins in source material include B-complex vitamins (B1, B2, B3, B5 in trace amounts) and ergosterol-derived vitamin D2 upon UV exposure. Bioavailability notes: Ganoderic Acid D is lipophilic with relatively low aqueous solubility, resulting in limited oral bioavailability estimated at roughly 5–15% without enhancement. Bioavailability is improved by co-administration with lipid-based carriers, liposomal formulations, or ethanol-based extracts. Dual extraction methods (hot water + ethanol) are commonly used to co-extract both water-soluble polysaccharides and alcohol-soluble triterpenoids including Ganoderic Acid D. Spore-cracked preparations may yield higher triterpenoid concentrations (up to 2–3× compared to intact spores) due to improved release from the chitinous spore wall. Hepatic first-pass metabolism may further reduce systemic availability; CYP450-mediated biotransformation has been suggested but not fully characterized for this specific ganoderic acid.
Reported Mechanism (Provisional)
Ganoderic acid D inhibits nuclear factor-kappa B (NF-κB) signaling pathway, reducing pro-inflammatory cytokines like TNF-α and IL-6. The compound activates Nrf2 antioxidant response elements in hepatocytes, increasing glutathione production and phase II detoxification enzymes. It also modulates T-cell proliferation by affecting calcium signaling and protein kinase C pathways.
Clinical Narrative (Provisional)
Limited human clinical trials exist specifically for isolated ganoderic acid D, with most research conducted on whole Ganoderma lucidum extracts containing this compound. In vitro studies demonstrate significant anti-inflammatory effects at concentrations of 10-50 μM, while animal studies using 20-100 mg/kg doses show hepatoprotective benefits. A small human study (n=68) using reishi extract containing ganoderic acids showed 15-20% improvement in liver enzyme markers over 12 weeks. More targeted clinical research on isolated ganoderic acid D is needed to establish definitive therapeutic dosages.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.